您当前的位置:
首页 >
文章列表页 >
Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs
更新时间:2026-02-28
    • Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs

      增强出版
    • Expert research has found that Danlou tablets can effectively reduce platelet activation and aggregation, and have good therapeutic effects on coronary heart disease with phlegm blood stasis syndrome in small pigs. Its pharmacological mechanism involves regulating biological pathways such as actin cytoskeleton and platelet activation pathway, as well as proteins such as GRB2 and RAC2.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 5, Pages: 41-53(2026)
    • DOI:10.13422/j.cnki.syfjx.20252206    

      CLC: R289;R259;R285
    • Received:06 August 2025

      Revised:2025-10-13

      Accepted:20 October 2025

      Online First:29 October 2025

      Published:05 March 2026

    移动端阅览

  • WANG Ziyan,LI Ying,WANG Aoao,et al.Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(05):41-53. DOI: 10.13422/j.cnki.syfjx.20252206.

  •  
  •  

0

Views

30

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect and Mechanism of Xiao Qinglongtang Against Right Ventricular Dysfunction in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline
Effect and Mechanism of Xiao Qinglongtang Against Right Ventricular Dysfunction in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline
Proteomics-based Investigation of Therapeutic Effect and Mechanism of Verbenalin on Lung Injury in Mice Infected with Human Coronavirus-229E
Mechanism of Huangqi Gegen Decoction in Treatment of Type 2 Diabetes Mellitus via Intestinal Mucosal Barrier

Related Author

QI Lei
ZHANG Huifei
GONG Ling
HE Jifu
CHEN Wenjing
NIU Weipin
LI Xiao
JIANG Yuehua

Related Institution

The Affiliated Hospital of Shandong University of Traditional Chinese Medicine(TCM)
Shandong University of TCM
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Shanxi Key Laboratory of Innovative Drug for Treatment of Serious Diseases Basing on Chronic Inflammation,College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine
Natural History Museum of China
0